Barclays Sticks to Its Buy Rating for EssilorLuxottica SA (0OMK)
Barclays analyst Hassan Al-Wakeel maintained a Buy rating on EssilorLuxottica SA today and set a price target of €355.00.
Claim 30% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Al-Wakeel covers the Healthcare sector, focusing on stocks such as EssilorLuxottica SA, Straumann Holding AG, and Fresenius Medical Care AG & Co. KGaA. According to TipRanks, Al-Wakeel has an average return of -1.6% and a 43.88% success rate on recommended stocks.
In addition to Barclays, EssilorLuxottica SA also received a Buy from RBC Capital’s Piral Dadhania in a report issued on March 23. However, yesterday, TipRanks – OpenAI reiterated a Hold rating on EssilorLuxottica SA (LSE: 0OMK).
The company has a one-year high of €323.80 and a one-year low of €190.70. Currently, EssilorLuxottica SA has an average volume of 680.6K.
Read More on GB:0OMK:
Disclaimer & DisclosureReport an Issue
- Meta, EssilorLuxottica debate over price of smart glasses, Bloomberg says
- EssilorLuxottica price target lowered to EUR 335 from EUR 345 at JPMorgan
- EssilorLuxottica reports Q4 revenue ex-FX up 18.4% to EUR 7.6B
- EssilorLuxottica price target lowered to EUR 315 from EUR 339 at Citi
- EssilorLuxottica: Rich Valuation and Strategic Tech Pivot Justify Market-Perform (Hold) Rating
